Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Mariola
Mariola Fotin-Mleczek, Sindelfingen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100061932 | PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES - The present invention is related to a peptide having an amino acid sequence comprising at least 8 consecutive amino acids of the human lactoferrin protein or of the bovine lactoferrin protein, whereby the peptide is suitable to act as a cell-penetrating peptide. | 03-11-2010 |
| 20100203076 | COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION - The present invention relates to a complexed RNA, comprising at least one RNA complexed with one or more oligopeptides, wherein the oligopeptide, which has the function of cell-penetrating peptide (CPP), has a length of 8 to 15 amino acids and has the empirical formula (Arg) | 08-12-2010 |
| 20110250225 | COMPOSITION COMPRISING A COMPLEXED (M)RNA AND A NAKED MRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOF - The present invention relates to an immunostimulatory composition comprising a) an adjuvant component, comprising or consisting of at least one (m)RNA, complexed with a cationic or polycationic compound, and b) at least one free mRNA, encoding at least one therapeutically active protein, antigen, allergen and/or antibody, wherein the immunostimulatory composition is capable to elicit or enhance an innate and optionally an adaptive immune response in a mammal. The inventive immunostimulatory composition may be a pharmaceutical composition or a vaccine. The invention furthermore relates to a method of preparation of the inventive immunostimulatory composition. The invention also relates to the use of the inventive immunostimulatory composition or its components (for the preparation of a pharmaceutical composition or a vaccine) for the treatment of various diseases. Finally, the invention relates to kits containing the inventive immunostimulatory composition, its components and/or the pharmaceutical composition or vaccine. | 10-13-2011 |
Mariola Kopcinski, Hawthorne Woods, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090137391 | Use of benzyladenine to improve emergence of seeds treated with abscisic acid - This invention relates to the use of N | 05-28-2009 |
Mariola Proszowski, Desplaines, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090114416 | FLEXIBLE INSULATED WIRES FOR USE IN HIGH TEMPERATURES AND METHODS OF MANUFACTURING - Flexible insulated wires for use in a high temperature environment are provided. In an embodiment, the wire includes a conductor and a coating over the conductor. The coating is formulated from a dielectric material and an organic binder having an organic component, wherein the organic component has been substantially decomposed from the coating during manufacture. The flexible insulated wire may be incorporated into a component. Methods of forming the flexible insulated wire are also provided. | 05-07-2009 |
Mariola S+e,uml O+ee Hngen, Aachen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110294843 | ADMINISTRATION SCHEME OF POLAR OPIOID METABOLITES FOR POST-OPERATIVE PAIN MANAGEMENT - Administration scheme of an analgesically active polar metabolite of an opioid or the salt thereof for the manufacture of a medicament for the treatment of pain after medical operation, whereas the medicament is administered at least once before the end of the medical operation. | 12-01-2011 |
Mariola Söhngen, Aachen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090004176 | NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE - The invention pertains to the use and production of non-neurotoxic plasminogen activating factors e.g. of | 01-01-2009 |
| 20100272704 | NOVEL PATIENT SUBGROUPS FOR THROMBOLYSIS - A method for treating a stroke patient with thrombolysis, wherein prior to treatment the patient is diagnosed in particular for exhibiting cerebral tissue at risk, a cerebral artery occlusion, and/or an absolute “mismatch volume”. | 10-28-2010 |
Mariola Söhngen, Aachen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100272704 | NOVEL PATIENT SUBGROUPS FOR THROMBOLYSIS - A method for treating a stroke patient with thrombolysis, wherein prior to treatment the patient is diagnosed in particular for exhibiting cerebral tissue at risk, a cerebral artery occlusion, and/or an absolute “mismatch volume”. | 10-28-2010 |
Mariola Wanior, Erlensee DE
| Patent application number | Description | Published |
|---|---|---|
| 20090045138 | Superabsorbent Foam, Method for the Production Thereof, and Use Thereof - Superabsorbent foam comprising superabsorbent fiber and/or fruit fiber, processes for producing superabsorbent foam having improved wet strength by foaming a crosslinkable aqueous mixture comprising at least 50 mol % neutralized acid-functional monoethylenically unsaturated monomer or at least one basic polymer, crosslinker, superabsorbent synthetic fiber and/or fruit fiber and at least one surfactant and subsequently polymerizing the monomer in the foamed mixture or crosslinking the basic polymer to form a hydrogel foam and use of the thus obtainable foam in hygiene articles to absorb body fluids, in dressing material to cover wounds, as a sealing material, as a packaging material, as a soil improver, as a soil substitute, to dewater sludges, to thicken waterborne paints or coatings in the course of disposing of residual quantities thereof, to dewater water-containing oils or hydrocarbons or as a material for filters in ventilation systems. | 02-19-2009 |
| 20090045378 | Use of Water-Absorbent, Predominantly Open-Celled Crosslinked Acid-Functional Addition Polymer Foams in Hygiene Articles - Use in hygiene articles of articles formed of water-absorbent, predominantly open-celled crosslinked acid-functional addition polymer foams Abstract The use of articles formed of water-absorbent open-celled crosslinked acid-functional addition polymer foams and containing finely divided silicon dioxide and/or at least one surfactant on their surface as an acquisition and/or distribution layer in hygiene articles. | 02-19-2009 |